Article Text
Abstract
Background Isolated positive para-aortic lymph node metastasis in endometrial cancer is an uncommon event, ranging from 1% to 3%.
Objective Our aim was to evaluate the impact of sentinel lymph node (SLN) mapping on the risk of isolated positive para-aortic lymph node metastasis.
Methods We retrospectively evaluated a series of 426 patients who underwent SLN mapping with at least one SLN detected from January 2013 to December 2021 (SLN group) compared with a historical series of 209 cases who underwent a systematic pelvic and para-aortic lymphadenectomy between June 2007 and April 2015 (LND group). Isolated para-aortic lymph node metastasis recurrences were included in the SLN group analysis.
Results In the SLN group, 168 cases (39.4%) had backup systematic lymphadenectomy, and 56 (13.1%) had positive lymph nodes compared with 34 (16.3%) in LND group (p=0.18). The SLN group had higher rates of minimally invasive surgeries (p<0.001) and presence of lymphovascular space invasion (p<0.001). Moreover, SLN group had fewer other uterine risk factors, such as high-grade tumors (p<0.001), and deep myometrial invasion (p<0.001). We found that SLN mapped outside the pelvis at pre-sacral, common iliac areas, and para-aortic regions in 2.8% (n=12), 11.5% (n=49), and 1.6% (n=7) of cases, respectively. Overall, 52 (12.2%) patients had positive SLNs, and 3 (5.7%) positive SLNs were found outside the pelvis—one in the pre-sacral region, one in the common iliac area, and one in the para-aortic region. An isolated para-aortic lymph node was found in only 2 (0.5%) cases in the SLN group compared with 7 (3.3%) cases in the LND group (p=0.004).
Conclusions SLN protocol accurately predicts lymph node status and may decrease the risk of failed identification of isolated para-aortic lymph node metastasis compared with systematic lymphadenectomy.
- Sentinel Lymph Node
- Lymphatic Metastasis
- Retroperitoneal Space
- Endometrial Neoplasms
- Lymph Nodes
Data availability statement
Data are available upon reasonable request. The data and material will be available by the authors upon reasonable request.
Statistics from Altmetric.com
Data availability statement
Data are available upon reasonable request. The data and material will be available by the authors upon reasonable request.
Footnotes
X @jaacqueline, @glaucobaiocchi
Contributors Study concept and design: JNM, GBa; Data acquisition: JNM, LDB, GBo, BG, LYK, CCF, GBa; Quality control of data: JNM, CCF, GBa, LDB; Data analysis and interpretation: JNM, LYK, LB-F, LDB, APGG, GBo, GBa; Statistical analysis: JNM, GBa; Manuscript preparation and editing: JNM, BG, GBa; Manuscript review: all authors; Guarantor of the manuscript: GBa.
Funding This study was partially sponsored by Brazilian National Research Council (CNPq) #307703/2019-3.
Competing interests GB reports honoraria and consulting from Astra Zeneca, GSK, and MSD.
Provenance and peer review Not commissioned; externally peer reviewed.